v-Fluence responds to hacking by blogger - v-fluence - BIG Pharma - AstraZeneca

The spin machine moves into full gear now. So let's set the record straight. "I did not hack into v-fluence".

These accusations published on their web site are complete fabrication by the spin doctors themselves. They left their site door wide open to public viewing, and I simply peered in and have brought their seedy practices to everyone's attention on this blog.

This is a typical response from these kinds of corporate entities. As they say in the PR biz, "Kill the Messenger, Kill the message". Nice try v-fluence, but slander will get you no where.

Now would you like to comment on keeping secret files on individuals and blogs? Is this incident reflecting badly on your business model and huge corporate clients? How much will this cost you Mr. Byrne?

I certainly would like "full disclosure" on how much and what kinds of information has been gathered by your company and how is it being used by your clients. Please spin these questions to your advantage now. This isn't MAD COW were talking about, this is an issue of private corporations gathering information and creating files on private citizens.

I'll be waiting with breathless and baited anticipation for your response here Mr. Byrne.

May I quote you here Mr Byrne: "Think of the Internet as a weapon on the table. Either you pick it up or your competitor does - but somebody is going to get killed."

If this is actually what you believe Mr. Byrne, then you better check your weapon, because at this juncture you're shooting nothing but blanks.

Of course for those who wish to know more about your business tactics Mr. Byrne, I suggest they read - http://spinprofiles.org/index.php/Jay_Byrne

( appears this link now directs you to their main page, just type "Jay Byrne" into their search engine and page displays)
____________________________________________________

http://www.v-fluence.com/news/462/v-fluence-responds-to-hacking-by-blogger

v-Fluence responds to hacking by blogger

(30 April 2010, St. Louis, MO)

On April 29th a blogger gained inappropriate access to a v-Fluence Interactive server Web portal used by our Internet content screeners and analysts to code monitoring data. This unethical hacking was limited to an out-of-date application on a monitoring data entry portal and one occurrence by this one unauthorized user. At no time was any v-Fluence client-owned or proprietary client information accessible via this portal and no such data were compromised.

The only data available on this space were links to publicly available Internet content with draft excerpts and historical analysis summaries of that content. The screen shot reveals v-Fluence images of Internet monitoring systems and protocols established to support U.S. Food and Drug Administration regulatory compliant reporting associated with potential adverse events and other regulated content for pharmaceutical, medical device and similar regulated healthcare organizations. No company e-mail, legal or other files were housed on this server. No other servers or v-Fluence company content were compromised.

This illegal access of a protected computer was conducted by a blogger following a log file from a monitoring bot from which he gained unauthorized access to one data entry portal hosted on one of our servers. This blogger then collected a screen shot of this content for purposes of publicly distributing the data in an attempt to cause reputational damage to our company and clients by name. This unauthorized access was immediately identified by our data and software management team and traced back to the source. The hacked server was closed as a precaution and the application through which the hacker gained unauthorized access was removed.

While no specific client data was breached, we take any illegal and authorized access of a v-Fluence computer seriously and report such cybercrime activities to the appropriate authorities.

For more information please contact info@v-Fluence.com or call (877) 835-8362.

____________________________________________________


Related links: from B-NET bnet-pharma

AstraZeneca's "Man Behind the Curtain" Moment: Company's Blog Monitoring Database Is Hacked

By Jim Edwards
Apr 30, 2010

'AstraZeneca\'s "Man Behind the Curtain" Moment: Company\'s Blog Monitoring Database Is Hacked'

"AstraZeneca's man behind the curtain is Jay Byrne of the v-Fluence PR firm."

AstraZeneca (AZN) woke up to a PR headache this morning when a mental health blogger got hold of a database created to monitor web coverage of its antipsychotic drug Seroquel. Although the database doesn’t contain any specific gaffes, it’s still something of a “Pay no attention to that man behind the curtain!” moment for the company.

Everyone knows pharmaceutical companies monitor bloggers who cover the drug business. But they don’t usually let bloggers see the results of their surveillance, which is what makes this incident so fascinating. Seroquel is a touchy subject for AZ right now, as it is facing thousands of lawsuits claiming the company failed to warn patients that a side effect of the drug is weight gain. Seroquel is one of AZ’s best-selling drugs.

The database, as published on the blog “Is Something Not Quite Right With Stan,” is tricky to navigate. But the best results can be had by clicking on field under “Annotation Groups.”

That drop-down menu lists all the headlines that the database tracked in that period. Some of the results are inane:

Actor Jim Carrey splits with Jenny McCarthy

Others are clearly spot on:

Pharmagossip amplifies DIDA documents that reveal “connection” between SEROQUEL and crisis consultant.

That last one was probably a reference to this item. AZ had this to say:

We believe it is important to read what is written about the business and our medicines to better understand issues that are important to journalists, bloggers and the public.

The database was prepared by v-Fluence, a pr firm employed by AZ. The agency’s chief, Jay Byrne, published a blog item this morning explaining why drug companies monitor web coverage. Big Food conspiracy theorists can look here for more information on Byrne, a former director of public affairs for Monsanto.


Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. Follow him on Twitter or send him an email@ jimedwards123@hotmail.com


______________________________________________________



UPDATE April 30, 2010

Since it has been said in the PR fantasy-land " there is no such thing as bad press, just press". I would like to pass along this link and post it as a gift to Jay Byrne,v-Fluence, and their client Astra Zeneca. I hope you have fun spinning this one also Mr. Byrne.

AstraZeneca's PR Machine Caught With Their Pants Down!

Image: theworldofhowey.files.wordpress.com

From a true advocate and brave blogger with integrity @ SEROXAT SUFFERERS - STAND UP AND BE COUNTED

I Personally "Thank You", very funny Fid

additional links: @ Pharmagossip

Jay Byrne - V-Fluence and the AstraZeneca Seroquel connection

AstraZeneca - Seroquel : V-FluenceGate, Stan writes

@ Pharma Conduct

Mental Health Blogger Creates a Seroquel Public Relations Nightmare for AstraZeneca

@ Beyond Conformity

Conformity, compliance and control.

A BRAVE NEW WORLD -Big Brother/Pharma Hires data miners and PR firms to track individuals and blogs as part of their huge spin campaign

A BRAVE NEW WORLD -Big Brother/Pharma hires data miners and PR firms to track individuals and blogs as part of their huge public perception/spin/image campaign machine

Who would have thought a little blog like mine and maybe yours were so damned important that Pharmaceutical Corporations would hire huge PR data mining firms to keep a watchful eye on us.

Yes, they rate us, write reports, even suggest a response strategy, and then take all this gathered analytical analysis to Big Brother (whoops typo: Big Pharma).

This is just one segment of the huge "Spin Machine" that is used to take any possible negative news or revelation about the "Sacred Pharmaceutical Cash Cow" to task, while reacting to any descent or counter messages in real living time.

In fact the companies the pharmaceutical Industry hire pride them selves publicly in their ability & stellar track records of taking any kind of serious negative fact/information, and then turning into a profitable positive fiction through controlling/manipulating the information, the message, the media, and in the end the highly valued public perception.

Companies like V-Fluence working for Corporations are watching us no doubt.

Just recently I had written about Robert Whitaker's New Book "Anatomy of an Epidemic".

When I happened to stumble upon a revealing tracking page VIA V-fluence the PR Firm (hired gun) working for no other than AstraZeneca Corporation.

So through my secretly held guarded trade nanotechnology methodology, and some highly honed intergalactic correspondence skills ( in other words known as pure "dumb luck"), I was able to open this interesting little page/document.

_____________________________________________________

http://www.vf02.com/php/monitor_annotate_handleOne_PageRelevantTopic.php?topic_id=157&page_id=93091657495ab3fb616957da34fc8106&page_id_suffix=1&secondEvaluator=1&fromDate=&cannotReturnToList=1&toDate=&userid=&assocArrayRelevanceCodesChecked=&fromOEO=1

Back

Logout

Relevance: None Selected Reported Aggregate Not Determined- No Action Real time Relevant No action Not Relevant- No action
Preliminary evaluation was not made.

Not Reviewed by Client Lead
Reviewed by Client Lead

Annotation Groups:

Remove from Group Litigator site alleges wrestler Chris Kanyon’s death “highlights the risk of SEROQUEL side effects” About Lawsuits and Drug Recall Lawyer Blog litigators amplify news of Florida appeals court ruling in SEROQUEL MDL case Indiana University researchers refine DNA testing for predisposition for bipolar disorder, predictive value potentially “useful in screening before the disorder manifests itself clinically” Psychology Today blogger fears that permitting clinical psychologists to prescribe medications will diminish critical role of psychotherapy in treating mental illness Blogger comments on Lilly Zyprexa off-label marketing settlement with Louisiana Letter to editor notes increase in price of drugs, including SEROQUEL Woman involved in theft charged for having SEROQUEL without prescription Highlands Today reports bipolar inmate denied SEROQUEL based on cost Blogger describes adverse events on various psychiatric meds Corlux being developed to treat psychotic depression Recession creates depression Meds used to treat childhood schizophrenia not shown to be effective Saudi national association seeks to raise awareness about schizophrenia Population growth in Australia could increase schizophrenia rates Pregnancy in warzone increases offspring’s schizophrenia risk due to fetal stress Suven Life Sciences granted Japanese NCE patent for candidate to treat cognitive issues associated with schizophrenia and related diseases Schizophrenia link to traumatic brain injury debated Discussion of the length of a typical bipolar disorder episode Bipolar disorder as cause of child suicide Marijuana use increases rapid cycling of moods in those with bipolar disorder AHRQ reports bipolar disorder and depression among top reasons uninsured hospitalized UAB researchers looking for proteins and genes involved in bipolar disorder Managing bipolar disorder Bipolar disorder can affect school performance of children Fish oil can treat bipolar disorder NADD advocates mindfulness as a treatment for those fighting mental illness along with developmental disabilities Study finds mental illness does not impact weight loss after bariatric surgery Depression blog discusses finding medical information online, importance of not self-treating Bipolar blog offers suggestions about what to have packed for a psychiatric hospitalization Pathologizing our children with mental illness—new trend Book review “The Strong Women’s Guide to Mental Health” According to Decision Resources, surveyed psychiatrists believe Zyprexa has “efficacy advantages” over “sales-leading” SEROQUEL for bipolar mania; Zyprexa to retain “clinical gold standard status” for bipolar mania through 2018 Patriot Ledger reports details of Rebecca Riley’s treatment with SEROQUEL, other drugs from psychiatrist’s testimony Pharmagossip revisits Liu Bolin affair, sarcastically wonders if SEROQUEL is sponsoring the artist’s new exhibit Invega Sustenna earns Decision Resources’ “clinical gold standard” for treatment of schizophrenia in 2013 SEROQUEL listed among drugs with looming patent expiry Traction – Decision Resources bipolar mania treatment report Review of book about mentally ill soldier treated with SEROQUEL and sent back to Iraq war front who rapes and murders Iraquis Blogger describes challenges with sedation effect of SEROQUEL Abbott ordered to turn over CEO’s emails in on-going federal probe into allegations of off-label marketing of Depakote as a treatment for agitation and aggression in the elderly Pfizer payment for off-label marketing of Geodon noted in article on Medicaid fraud cleanup in NY Training for nursing home staff can reduce antipsychotics misuse Blogger balancing SEROQUEL and Abilify use CBT as adjunct treatment for schizophrenia Schizophrenia talk announced for healthcare conference Traction – Antipsychotics linked to increased risk of pneumonia in elderly Broadway play about family struggle with mother\\\\\\\'s bipolar disorder wins Pulitzer Prize Getting those with bipolar to stay on their meds is one way way to cut healthcare costs Children of older fathers at increased risk of bipolar and schizophrenia Bipolar teen on trial for school stabbing murder Discussion of Chris Kanyon's death as a suicide caused by his bipolar disorder Former Michigan county jail inmate has filed federal lawsuit against jail and its staff for denying him his bipolar meds for one week Suicide risk the same for children on antidepressants, no matter what the brand Mindfulness as treatment for those with coexisting mental illness and developmental disabilities Overview of controversy surrounding DSM-5 draft proposed changes Canadian researchers find “new” mutations in SHANK3 gene to be cause of “significant” number of schizophrenia cases Pharmagossip amplifies DIDA documents that reveal “connection” between SEROQUEL and crisis consultant Wayne L. Pines CCHR St. Louis amplifies Evelyn Pringle piece on psychiatric drugs in children, six “action steps” (including helping “victims of human rights abuses by psychiatrists obtain justice”) added Epsilon study shows Internet users finding valuable information through health websites, social media outlets; “significant opportunities” for pharma marketers noted Traction – Rosenberg piece on SEROQUEL drug “cocktails” for PTSD and soldier suicides Rosenheck quoted (again) on how CATIE did not affect sales of atypical antipsychotics Hallucinogens being investigated as a treatment for multiple mental illnesses Atypical antipsychotic therapy can boost the effect of antidepressants Local scientists identify keys to bipolar in Chinese How to come off antipsychotics and other mental health drugs Traction – development of bipolar disorder lab test prototype J&J pushed drugs (including antipsychotic) on seniors Conference presentation emphasizes importance of continuity of care for schizophrenia patients following hospitalization Impairment of visual working memory linked to schizophrenia and dementia Bipolar disorder in children Treatment and therapy options for bipolar Traction – mutation in SHANK3 gene linked to schizophrenia Nutrient therapy (with or without meds) can improve bipolar disorder Adolescent marijuana abuse linked to schizophrenia development Bipolar disorder and treatment overview Orthomolecular medicine can treat schizophrenia Actor Jim Carrey splits with Jenny McCarthy Columnist describes experience with bipolar and notes meds can be effective to normalize life PHQ s9 screen for depression does not discriminate between condition and similar illnesses like bipolar Oregon governor vetos bill that would have allowed some psychologists to prescribe meds Overview of mental illness and treatment Traction – Psychology Today blog post on “irrational” polypharmacy of psychiatric meds pimavanserin found safe and well-tolerated in clinical trial for PDP MSM report on progress of Florida’s “Gabriel Myers Bill” notes dead child’s SEROQUEL use; amplified by AboutLawsuits.com Pharmagossip amplifies DIDA document purportedly listing AZ SEROQUEL payments to psychiatrist Michael Reinstein Rexahn’s Serdaxin fails in mid-stage trial for major depressive disorder; despite the news, principal investigator claims drug’s effect “very encouraging” Psychiatrists criticize practice of “irrational psychiatric polypharmacy”; About.com Bipolar Blog amplifies post by emphasizing medication adherence Bipolar rocker talks about how medication is helping him Woman who is bipolar and pro-medication discusses her experience in context of promoting book about it Genetic links to bipolar disorder identified in Chinese Traction -- anticonvulsants used to treat bipolar raise suicide risk Bipolar is among common reasons women are hospitalized AHRQ study finds Bipolar blogger vacillates between meds or therapy as treatment Traction - Progress report on Gabriel Myers Bill in Florida mentions dead boy’s SEROQUEL use Traction – Pharmagossip posting of DIDA document purporting to list SEROQUEL payments to Reinstien Antipsychotics can treat intractable hiccups Nursing homes won’t tell you that they are “careless” about the drugs they give out, including anitpsychotics Traction – Alaska Northern Lights light box treatment for bipolar Fish oil can treat bipolar Traction – Mutation in SHANK3 gene linked to schizophrenia Missing portion of chromosome 16 linked to schizophrenia and seizure disorders NAMI launching new online community for college-age adults called strengthofus.org Severely mentally ill people are more likely to die of CVD Talk radio show focuses on how mentally ill view world Review of Whitaker book on mental illness epidemic “America’s Medicated Kids” video documentary to air on BBC, bipolar child on SEROQUEL featured Natural News article alleges “poor children more likely to be put on antipsychotic drugs” in recycled December 2009 New York Times coverage Anticonvulsant drugs used to treat bipolar disorder found to increase suicide risk; Broadway musical about family’s struggles with mother’s bipolar disorder wins Pulitzer Prize Maine reforms mental illness treatment laws to improve medication adherence among patients Aboriginal Australian dies from potentially lethal injections of unnamed antipsychotic drugs Police arrest woman for possessing drugs, including Seroquel Director of “America’s Medicated Kids” discusses bipolar disorder in the documentary Psychiatrist speaks about links between bipolar and similar mental illness with creative genius Treatment costs keep bipolar disorder undiagnosed or misdiagnosed in the African American community NAMI awards Montana man for raising bipolar awareness in the state “The Protest Psychosis” links over-diagnosis of schizophrenia among African Americans with 1960s protest culture New Zealand hosts global seminar on schizophrenia in May Columnist worries that health care reform may lead to diminished resources for mental illness from insurance companies Traction – Natural News reports poor children more likely to be put on antipsychotics Traction – Rosenberg piece on PTSD treatment with SEROQUEL drug cocktails and soldier suicides Gerson Lehman analyst suggests Saphris may improve compliance because is sublingual Blogger argues B-12 could potentially end the bipolar epidemic Blogger recommends CBT for schizophrenia treatment Traction – anticonvulsants to treat bipolar increase suicide risk Cafepharma AZ company board participant urges sales reps to turn over proof of off-label SEROQUEL marketing to state AG offices Pharmagossip once again attempts to connect AZ SEROQUEL with crisis communications consultant Wayne L. Pines Dr. Reddy’s recalls 78, 876 bottles of Risperidone in the United States Medical College of Wisconsin to investigate relationship between marijuana use and bipolar disorder “Anatomy of an Epidemic” book review questions author’s claim that growing mental illness among children is due to adverse events from psychiatric drugs

Filter Annotation Groups:
One Week 30 Days Show All

Optional Shared Fields
Excerpt
Background
Monitor Notes

This URL is the Source URL of its group

URL:

http://bipolar-stanscroniclesandnarritive.blogspot.com/2010/04/anatomy-of-epidemic-by-robert-whitaker.html

Title:

MetaTitle:

Distribution Type:

None Selected Web 1.0: Web site- News/News Aggregator Web 1.0: Web site- Portal/ Reference Web 1.0: Web site- New Domain Registry Web 1.0: Web site- Index/Search Engine/Directory Web 1.0: Web site- Other Web 1.0: e-Mail Web 2.0: Content-Aggregator Blog Web 1.0: Web site- Forum/Community Web 2.0: Social Network Web 2.0: Wiki Web 2.0: Multi-Media Index Web 2.0: Authored Blog Web 1.0: Web site- e-Commerce Web 2.0: Other Deep Web

Content Type:

None Selected Call-to-Action Commentary/Opinion News/Announcement New Development Advertising

Content Source:

None Selected Academic Commercial-Association Commercial-Individual Business Government Litigator Media NGO-Advocacy NGO-Philanthropy NGO-Professional NGO-Service Delivery Other/Unaffiliated

Industry:

Type:

None Selected Specific tactic General case study Other metric Other

Evaluation:

None Selected Success Failure Mixed N/A

Topic:

Bipolar & Schizophrenia

Topic Categories:

Category	Sub-category
IR - Other

Online Influence:

Select One Low Moderate High

Online Environment:

No information available

Slant:

Select One Favorable Neutral Balanced Negative

Date Found:

04/19/2010

Summary:
No AstraZeneca or brand-specific mention. [emphasis added] In an unfavorable review posted on both Boston.com and his blog on Psychology Today, Dennis Rosen is criticizing the central theme of journalist Robert Whitaker’s book “Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America.” More specifically, the review takes issue with the idea that drug companies and “crooked physicians” are directly responsible for the escalating rates of mental illness documented in the United States since World War II. Rosen argues that the book “gives undue attention to isolated, admittedly tragic, case studies and fails to form a cohesive chain of evidence by stringing together poorly-researched, unreliable narratives,” before emphasizing that “hypothesis is no substitute for data.” In response, Whitaker amplifies the post via his blog (also hosted on Psychology Today), making the claim that Rosen’s criticism focused on short-term examples while his book was written primarily to present readers with long-term data: I reviewed 50 years of outcomes literature for four major adult disorders: schizophrenia, anxiety, depression and bipolar illness. I did the same for three childhood disorders: depression, ADHD, and juvenile bipolar illness. I looked to see in particular whether psychiatric medications have altered the long-term course of the disorders for the better or for the worse, and also whether psychiatric medications could, at times, stir new and more severe psychiatric symptoms in patients. In other words, I looked to see whether this paradigm of care increased the risk that a person would become chronically ill, and ill too with disabling symptoms.

Analysis:
Both Rosen’s original criticism and Whitaker’s subsequent rebuttal have garnered little traction outside of the Psychology Today umbrella. Last year, v-Fluence reported Whitaker’s attempt to attend the annual meeting of the American Psychiatric Association, held in May. The APA typically bars non-members from admittance to case conferences due to their lack of confidentiality restrictions, but Whitaker’s publisher, Crown, intervened and secured access (see April 5, 2010 Snapshot). With a book to sell and this year’s APA conference approaching, v-Fluence will continue to monitor Whitaker’s activity. [see Background section for additional information]

Recommendations:

Recommendation Tactic:

Excerpt:

Background:

Notes:

Website User Info:

Language:

English Spanish none

OEO:

Infominder:

PDF:

Relevant Blog / DG:

Other Topics:

None

Last Updated:

04/19/2010

Web Site Name:

Domain Registrant:

No Stakeholder specified

____________________________________________________________

I believe the greater blogging community should be made aware of this document, the ethical, and full disclosure questions it brings along with it.

You should really scroll down and read under "Annotation Groups" to see if your blog has joined this illustrious group of the "watched".

Then peer under "Analysis" and ask your self this question; Are these Huge Corporations keeping and updating a ongoing watch file on you also.?

Yes Folks, we are living in a "BRAVE NEW WORLD" after all.

_________________________________________________________

UPDATE: April 29, 2010

Just clicked on the link and to my surprise it opens up again:

________________________________________________________

Back

Logout

Relevance: None Selected Reported Aggregate Not Determined- No Action Real time Relevant No action Not Relevant- No action
Preliminary evaluation was not made.

Not Reviewed by Client Lead
Reviewed by Client Lead

Annotation Groups:

Remove from Group Litigator site alleges wrestler Chris Kanyon’s death “highlights the risk of SEROQUEL side effects” About Lawsuits and Drug Recall Lawyer Blog litigators amplify news of Florida appeals court ruling in SEROQUEL MDL case Indiana University researchers refine DNA testing for predisposition for bipolar disorder, predictive value potentially “useful in screening before the disorder manifests itself clinically” Psychology Today blogger fears that permitting clinical psychologists to prescribe medications will diminish critical role of psychotherapy in treating mental illness Blogger comments on Lilly Zyprexa off-label marketing settlement with Louisiana Letter to editor notes increase in price of drugs, including SEROQUEL Woman involved in theft charged for having SEROQUEL without prescription Highlands Today reports bipolar inmate denied SEROQUEL based on cost Blogger describes adverse events on various psychiatric meds Corlux being developed to treat psychotic depression Recession creates depression Meds used to treat childhood schizophrenia not shown to be effective Saudi national association seeks to raise awareness about schizophrenia Population growth in Australia could increase schizophrenia rates Pregnancy in warzone increases offspring’s schizophrenia risk due to fetal stress Suven Life Sciences granted Japanese NCE patent for candidate to treat cognitive issues associated with schizophrenia and related diseases Schizophrenia link to traumatic brain injury debated Discussion of the length of a typical bipolar disorder episode Bipolar disorder as cause of child suicide Marijuana use increases rapid cycling of moods in those with bipolar disorder AHRQ reports bipolar disorder and depression among top reasons uninsured hospitalized UAB researchers looking for proteins and genes involved in bipolar disorder Managing bipolar disorder Bipolar disorder can affect school performance of children Fish oil can treat bipolar disorder NADD advocates mindfulness as a treatment for those fighting mental illness along with developmental disabilities Study finds mental illness does not impact weight loss after bariatric surgery Depression blog discusses finding medical information online, importance of not self-treating Bipolar blog offers suggestions about what to have packed for a psychiatric hospitalization Pathologizing our children with mental illness—new trend Book review “The Strong Women’s Guide to Mental Health” According to Decision Resources, surveyed psychiatrists believe Zyprexa has “efficacy advantages” over “sales-leading” SEROQUEL for bipolar mania; Zyprexa to retain “clinical gold standard status” for bipolar mania through 2018 Patriot Ledger reports details of Rebecca Riley’s treatment with SEROQUEL, other drugs from psychiatrist’s testimony Pharmagossip revisits Liu Bolin affair, sarcastically wonders if SEROQUEL is sponsoring the artist’s new exhibit Invega Sustenna earns Decision Resources’ “clinical gold standard” for treatment of schizophrenia in 2013 SEROQUEL listed among drugs with looming patent expiry Traction – Decision Resources bipolar mania treatment report Review of book about mentally ill soldier treated with SEROQUEL and sent back to Iraq war front who rapes and murders Iraquis Blogger describes challenges with sedation effect of SEROQUEL Abbott ordered to turn over CEO’s emails in on-going federal probe into allegations of off-label marketing of Depakote as a treatment for agitation and aggression in the elderly Pfizer payment for off-label marketing of Geodon noted in article on Medicaid fraud cleanup in NY Training for nursing home staff can reduce antipsychotics misuse Blogger balancing SEROQUEL and Abilify use CBT as adjunct treatment for schizophrenia Schizophrenia talk announced for healthcare conference Traction – Antipsychotics linked to increased risk of pneumonia in elderly Broadway play about family struggle with mother\\\\\\\'s bipolar disorder wins Pulitzer Prize Getting those with bipolar to stay on their meds is one way way to cut healthcare costs Children of older fathers at increased risk of bipolar and schizophrenia Bipolar teen on trial for school stabbing murder Discussion of Chris Kanyon's death as a suicide caused by his bipolar disorder Former Michigan county jail inmate has filed federal lawsuit against jail and its staff for denying him his bipolar meds for one week Suicide risk the same for children on antidepressants, no matter what the brand Mindfulness as treatment for those with coexisting mental illness and developmental disabilities Overview of controversy surrounding DSM-5 draft proposed changes Canadian researchers find “new” mutations in SHANK3 gene to be cause of “significant” number of schizophrenia cases Pharmagossip amplifies DIDA documents that reveal “connection” between SEROQUEL and crisis consultant Wayne L. Pines CCHR St. Louis amplifies Evelyn Pringle piece on psychiatric drugs in children, six “action steps” (including helping “victims of human rights abuses by psychiatrists obtain justice”) added Epsilon study shows Internet users finding valuable information through health websites, social media outlets; “significant opportunities” for pharma marketers noted Traction – Rosenberg piece on SEROQUEL drug “cocktails” for PTSD and soldier suicides Rosenheck quoted (again) on how CATIE did not affect sales of atypical antipsychotics Hallucinogens being investigated as a treatment for multiple mental illnesses Atypical antipsychotic therapy can boost the effect of antidepressants Local scientists identify keys to bipolar in Chinese How to come off antipsychotics and other mental health drugs Traction – development of bipolar disorder lab test prototype J&J pushed drugs (including antipsychotic) on seniors Conference presentation emphasizes importance of continuity of care for schizophrenia patients following hospitalization Impairment of visual working memory linked to schizophrenia and dementia Bipolar disorder in children Treatment and therapy options for bipolar Traction – mutation in SHANK3 gene linked to schizophrenia Nutrient therapy (with or without meds) can improve bipolar disorder Adolescent marijuana abuse linked to schizophrenia development Bipolar disorder and treatment overview Orthomolecular medicine can treat schizophrenia Actor Jim Carrey splits with Jenny McCarthy Columnist describes experience with bipolar and notes meds can be effective to normalize life PHQ s9 screen for depression does not discriminate between condition and similar illnesses like bipolar Oregon governor vetos bill that would have allowed some psychologists to prescribe meds Overview of mental illness and treatment Traction – Psychology Today blog post on “irrational” polypharmacy of psychiatric meds pimavanserin found safe and well-tolerated in clinical trial for PDP MSM report on progress of Florida’s “Gabriel Myers Bill” notes dead child’s SEROQUEL use; amplified by AboutLawsuits.com Pharmagossip amplifies DIDA document purportedly listing AZ SEROQUEL payments to psychiatrist Michael Reinstein Rexahn’s Serdaxin fails in mid-stage trial for major depressive disorder; despite the news, principal investigator claims drug’s effect “very encouraging” Psychiatrists criticize practice of “irrational psychiatric polypharmacy”; About.com Bipolar Blog amplifies post by emphasizing medication adherence Bipolar rocker talks about how medication is helping him Woman who is bipolar and pro-medication discusses her experience in context of promoting book about it Genetic links to bipolar disorder identified in Chinese Traction -- anticonvulsants used to treat bipolar raise suicide risk Bipolar is among common reasons women are hospitalized AHRQ study finds Bipolar blogger vacillates between meds or therapy as treatment Traction - Progress report on Gabriel Myers Bill in Florida mentions dead boy’s SEROQUEL use Traction – Pharmagossip posting of DIDA document purporting to list SEROQUEL payments to Reinstien Antipsychotics can treat intractable hiccups Nursing homes won’t tell you that they are “careless” about the drugs they give out, including anitpsychotics Traction – Alaska Northern Lights light box treatment for bipolar Fish oil can treat bipolar Traction – Mutation in SHANK3 gene linked to schizophrenia Missing portion of chromosome 16 linked to schizophrenia and seizure disorders NAMI launching new online community for college-age adults called strengthofus.org Severely mentally ill people are more likely to die of CVD Talk radio show focuses on how mentally ill view world Review of Whitaker book on mental illness epidemic “America’s Medicated Kids” video documentary to air on BBC, bipolar child on SEROQUEL featured Natural News article alleges “poor children more likely to be put on antipsychotic drugs” in recycled December 2009 New York Times coverage Anticonvulsant drugs used to treat bipolar disorder found to increase suicide risk; Broadway musical about family’s struggles with mother’s bipolar disorder wins Pulitzer Prize Maine reforms mental illness treatment laws to improve medication adherence among patients Aboriginal Australian dies from potentially lethal injections of unnamed antipsychotic drugs Police arrest woman for possessing drugs, including Seroquel Director of “America’s Medicated Kids” discusses bipolar disorder in the documentary Psychiatrist speaks about links between bipolar and similar mental illness with creative genius Treatment costs keep bipolar disorder undiagnosed or misdiagnosed in the African American community NAMI awards Montana man for raising bipolar awareness in the state “The Protest Psychosis” links over-diagnosis of schizophrenia among African Americans with 1960s protest culture New Zealand hosts global seminar on schizophrenia in May Columnist worries that health care reform may lead to diminished resources for mental illness from insurance companies Traction – Natural News reports poor children more likely to be put on antipsychotics Traction – Rosenberg piece on PTSD treatment with SEROQUEL drug cocktails and soldier suicides Gerson Lehman analyst suggests Saphris may improve compliance because is sublingual Blogger argues B-12 could potentially end the bipolar epidemic Blogger recommends CBT for schizophrenia treatment Traction – anticonvulsants to treat bipolar increase suicide risk Update: Cafepharma AZ board poster claims to have been deposed for Seroquel lawsuit Pharmagossip once again attempts to connect AZ SEROQUEL with crisis communications consultant Wayne L. Pines Dr. Reddy’s recalls 78, 876 bottles of Risperidone in the United States Medical College of Wisconsin to investigate relationship between marijuana use and bipolar disorder “Anatomy of an Epidemic” book review questions author’s claim that growing mental illness among children is due to adverse events from psychiatric drugs Drugs used to treat schizophrenia are growing targets for thieves Family of arsonist blames change of prescription from Zyprexa to an unnamed, different drug Zyprexa named as one of several drugs prescribed to Ohio man that shot a police officer and killed his K-9 CNN article details the rise of specialized online dating communities, including one for schizophrenics Diet guide suggests “bipolar super foods” for patients concerned about gaining weight from prescription drugs Traction – BBC airs “America’s Medicated Kids” documentary about prescription drug use among American children Warren Buffet’s sister, Doris, writes memoir detailing their mother’s undiagnosed bipolar disorder Hero saves Louisiana man, believed to be bipolar, from jumping off a bridge Glenn Close throws first pitch at Cardinals game, discusses bipolar awareness YouTube excerpt from forthcoming DVD discusses the positive aspects of bipolar delusions and hallucinations FDA approves Mylan’s generic Clozaril Allen Frances blogs that DSM5 is “unusable” Analyst pokes holes in Rexahn Pharmaceuticals’ positive spin on MDD drug Serdaxin’s failed trial Miami psychiatrist under scrutiny for prescribing drug cocktail, including Seroquel, that may have contributed to the May 2007 death of a 12-year-old autistic boy Martha Rosenberg includes Seroquel in “Treatment Resistant” Conditions section of post focused on the “8 invented diseases big pharma is banking on” Lilly reports 5% decline in Q1 earnings; despite increase in Zyprexa sales, looming patent expiration has analysts concerned over future market share Decision Resources report highlights AZ/Targacept’s TC-5214 as “gold standard” for MDD, potential for efficacy improvements over Seroquel XR cited BMJ article argues “sanctions for irregular marketing do really hurt drug companies” Traction – Decision Resources names TC-5214 gold standard for MDD in 2013; cites improvements over Seroquel XR Frances argues DSM5 overdiagnoses adult ADD, rather than properly screening for bipolar London murderer argues his bipolar disorder diminishes his responsibility Lawyers argue undiagnosed bipolar led high-school killer to hallucinate fantasy world, plead insanity Ten plead guilty to stealing veterans’ disability claims by falsely claiming bipolar disorder Florida mental health agencies “missed opportunities” to prevent bipolar woman’s death New York man missing after switching unnamed schizophrenia medications Cornell grad student murderer’s defense argues rare type of schizophrenia to blame Australian author writes “Blue Messiah”, a memoir of his institutionalization for schizophrenia Illinois inmate sues prison doctor for switching his schizophrenia meds without a valid license Mother stabs infant son, husband cites antipsychotic medication adherence difficulties IMS Health forecasts 5-8% drug sales growth despite patent losses of Seroquel and other top-sellers Traction -- Bloomberg finds stimulus package, new health bill drive interest in comparative effectiveness research Veteran with major depressive disorder finds therapy in conservationist projects Traction – Eli Lilly 1Q earns drop 5%; looming Zyprexa patent expiration has analysts concerned over market share Risperdal sales impacted by generic competition for Johnson & Johnson’s Q1 earnings; Risperdal Consta shows strong international growth Discovery Health launches “Psych Week” programming event, focuses on bipolar disorder and schizophrenia “Investigative journalist” Evelyn Pringle claims U.S. “has become the psychiatric drugging capital of the world for kids” with mental illnesses Report projects market forecasts for bipolar disorder drugs through 2015 Doctor clarifies differences between clinical depression and bipolar Bipolar woman off meds ordered to pay $6K for “air rage” in Russia California marijuana expo features on-site smoking; docs dispense for bipolar disorder Vets scam disability claims, fake bipolar Australian study finds local seniors prescribed antipsychotics in “astonishing” quantities Sacramento budget cuts could force 6,500 mentally ill from programs World Drug Safety Congress presentation on “Social Media and the Future of Adverse Event Reporting” San Diego Reader aggregates blog post accusing Zyprexa reps of overselling Lilly accused of raising Zyprexa prices before staging high-profile “sale” for HCR rebates Abilify sales growth jumped 17% in Q4 of last year FDA warns Pfizer of \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\"significant violations\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\" involving pediatric trials of Geodon In follow up post, “Investigative journalist” Evelyn Pringle targets the “medicalization of childhood” through “inventing disorders” UCSD sociology professor’s historical overview concludes “drug money has come to dominate psychiatry” Cops arrest Massachusetts couple for trafficking heroin, oxcycodone and Seroquel Chicago Tribune highlights bipolar group therapy trending from doctor-led therapy FAME, Canadian non-profit, supports family caregivers of bipolar loved ones and other mental illnesses Woman sentenced for 25 years after killing man who threw cheese balls at her car; bipolar defense failed Suicide rate for bipolar may be highest of all psychiatric conditions Schizophrenic actress writes play accusing psych wards of being “prison situation except with drugs” “Soloist” author continues to travel, promote schizophrenia awareness Schizophrenic man believed he was suffering from a curse, murdered mother’s boyfriend Ukraine man murdered three people with shovel to support Hitler, police blame schizophrenia Native American tribe settles lawsuits for misused blood samples that studied schizophrenia Lilly’s lowered earnings a bellwether for future of the industry NAMI lobbies Mississipi for new legislation for mental illness Veterans with major depressive disorder join Conservation Corps Traction – Pfizer warned by FDA over Geodon study violations Geriatrician argues antipsychotics, including SEROQUEL, should remain a last resort in national effort to curb prescription drug use New Scientist investigation finds Pfizer paid censured experts for Geodon lectures to doctors; pharma bloggers continue to weigh in on FDA warning over \\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\"significant violations\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\" involving pediatric trials of Geodon Analysts claim Eli Lilly “a victim of their own success” with future increased Medicaid rebates for Zyprexa MSM, health news sites amplify IMS Health report predicting global pharma sales to total $1 trillion by 2014 Bipolar Bear iPhone app raises Seroquel awarded for Best Consumer Campaign at Med Ad News Manny Awards Plavix patent expiration compared to Seroquel Satire piece parodies doctor diagnosing bipolar child with ADHD after being kicked in the shin Youth minister with bipolar disorder discusses faith, therapy and medication Trial for bipolar NBA player Delonte West postponed to July 21 Fountain House honors Glenn Close for mental illness advocacy England man details struggles finding help for schizophrenia NARSAD “Healthy Minds Across America” forum focuses on schizophrenia, mental illness Epidemiologist discusses infections commonly associated with schizophrenia Helping schizophrenics quit cigarette smoking Columnist argues that the media should stop using mental illness terminology as political slang SEROQUEL XR recommended for approval in Europe as add-on treatment for major depressive disorder Allen Frances argues against expanding bipolar II disorder in DSM5 because it “would increase antipsychotics and mood stabilizers use” Australian researchers say “brain oestrogen” shows promise as treatment for post-menopausal women with schizophrenia, results “could revolutionise treatment options for women with schizophrenia” Traction – Seroquel XR recommended for approval in EU Seroquel found in purse of mall shoplifters Seroquel earns ninth place on Psych Central’s Top 25 Psychiatric Drugs in 2009 Differentiating between bipolar disorder and common mood swings Omega-3 fatty acids may help treat bipolar disorder Columnist rebuts Frances’ argument against expanding bipolar II disorder PTSD, bipolar disorder cited for military suicides outpacing combat deaths in Iraq or Afghanistan Student newspaper highlights mental illness stigma on college campuses Alkermes portfolio update features once-monthly, injectable antipsychotic drug, ALKS 7921 Australian schizophrenic man describes falling through the cracks of governmental care Canadian media interviews Allen Frances, who continues his criticism that the DSM5 will create an “epidemic” of harmful psychiatric drug use YouTube user endorses SEROQUEL for bipolar-related insomnia CMSS promotes new voluntary code in effort to “reduce drug industry influence” on health care professionals Schizzophernia vs Antipsychotics News Update: New Jersey Court Rules in Astrazeneca's (NYSE: AZN) Favor on Seroquel Trial Same song and dance Eminem Florida Psychotropic Bill News Headlines, PTV News: Mar 19, 2010 Legal News Headline 3.19.2010 Epilepsy Vs Seroquel..wmv Making a Killing Drug Them or Disciple Them Psychotropic Medications in Pregnancy and the Effect on the Fetus and Child Brain dissection of notorious Australian gangland killer unlikely to yield insight into bipolar, mental illness Canadian author writes bipolar book targeted to teens and early twentysomethings GlobalData releases bipolar drug market projections to 2015 report University of Minnesota “flash mob” raises awareness of bipolar-related suicide Journalist questions undiagnosed bipolar disorder as cause for NFL running back Ricky Williams’ erratic behavior during his career Schizophrenic man beat son to death after the boy wet his pants Columbus schizophrenic found not guilty by reason of insanity for murder of his mother Author writes book of poetry about living with schizophrenia, “We Mad Climb Shaky Ladders” Judge orders schizophrenic man caught with child pornography to undergo treatment “in the community” rather than prison St. Louis man asks public for assistance finding his missing schizophrenic wife San Diego police shoot and kill schizophrenic man armed with kitchen knife Musician Roky Erickson describes his 40-year battle with schizophrenia and mental illness Alkemermes unveils development of extended-release Abilify, Zyprexa US military “very, very closely” monitoring “overmedication” of troops Sunshine Act requires pharma clients to disclose gifts to doctors AstraZeneca pays $520 million to settle federal investigations into SEROQUEL off-label marketing practices, coverage notes AZ fourth big pharma company to admit illegal marketing of antipsychotic drugs in three years Experts debate addition of “Temper Dysregulation Disorder” (TDD) to DSM5 as alternative to “runaway” pediatric bipolar disorder diagnoses Analysts concerned FDA warning for pediatric Geodon may impact patent extension Traction – AZ pays $520 million to settle federal investigations into SEROQUEL off-label marketing practices Phillipines presidential candidate allegedly takes Seroquel Traction – Experts debate addition of “Temper Dysregulation Disorder” (TDD) to DSM5 as alternative to “runaway” pediatric bipolar disorder diagnoses Natural News highlights “natural alternatives” for bipolar disorder treatment Allen Frances argues “practical consequences” should influence bipolar II classifications Mentally unstable suspects, including those affected by bipolar disorder, often resort to police shootings as a form of suicide Psychosis risk syndrome screens for teenage schizophrenia Toronto police issue YouTube appeal for missing schizophrenic woman Pharmalot post highlights physicians involved in FDA-warned Geodon pediatric trials Omnicare pays Kansas $687,650 for Medicaid scam involving Risperdal kickbacks SEROQUEL whistleblowers to share in $45 million AZ federal settlement; states announce their respective allocations Marcia Purse (“bipolar guide” on about.com) questions validity of Medical College of Wisconsin study investigating possible link between marijuana use and bipolar disorder Delaware Division of Health study finds drugs, including antidepressants, in state’s drinking water

Filter Annotation Groups:
One Week 30 Days Show All

Optional Shared Fields
Excerpt
Background
Monitor Notes

This URL is the Source URL of its group

URL:

http://bipolar-stanscroniclesandnarritive.blogspot.com/2010/04/anatomy-of-epidemic-by-robert-whitaker.html

Title:

MetaTitle:

Distribution Type:

None Selected Web 1.0: Web site- News/News Aggregator Web 1.0: Web site- Portal/ Reference Web 1.0: Web site- New Domain Registry Web 1.0: Web site- Index/Search Engine/Directory Web 1.0: Web site- Other Web 1.0: e-Mail Web 2.0: Content-Aggregator Blog Web 1.0: Web site- Forum/Community Web 2.0: Social Network Web 2.0: Wiki Web 2.0: Multi-Media Index Web 2.0: Authored Blog Web 1.0: Web site- e-Commerce Web 2.0: Other Deep Web

Content Type:

None Selected Call-to-Action Commentary/Opinion News/Announcement New Development Advertising

Content Source:

None Selected Academic Commercial-Association Commercial-Individual Business Government Litigator Media NGO-Advocacy NGO-Philanthropy NGO-Professional NGO-Service Delivery Other/Unaffiliated

Industry:

Type:

None Selected Specific tactic General case study Other metric Other

Evaluation:

None Selected Success Failure Mixed N/A

Topic:

Bipolar & Schizophrenia

Topic Categories:

Category	Sub-category
Brand - Seroquel

Online Influence:

Select One Low Moderate High

Online Environment:

No information available

Slant:

Select One Favorable Neutral Balanced Negative

Date Found:

04/19/2010

Summary:
emphasis added] In a blog entry, Pharmagossip is once again inferring a connection between AstraZeneca SEROQUEL and crisis communications consultant Wayne L. Pines. Specifically, Pharmagossip has posted a link to Pines’ e-book “Communicating in a Healthcare Crisis” under the headline “AstraZeneca – Seroquel: Wayne’s World!” The post is labeled with key words that include “atypical antipsychotics,” ”seroquel,” and “quetiapine.”

Analysis:
Earlier this week, a Pharmagossip entry suggested a “connection” between SEROQUEL and Wayne L Pines, a consultant who “helps companies…in crisis.” To support that assertion, Pharmagossip linked to DIDA material that appeared to show that AstraZeneca considered hiring Pines to provide services to the SEROQUEL team (see Snapshot April 13, 2010). Previously, v-Fluence reported a Pharmagossip blog post which amplifed an emailed announcement by Kim Klausner, Industry Documents Digital Libraries Manager, University of California, San Francisco (UCSF), that 241 SEROQUEL marketing documents had been added to UCSF Drug Industry Document Archive (DIDA). Klausner credited a Florida newspaper (the St. Petersburg Times) and a law firm involved in the litigation (Blizzard, McCarthy and Nabers) for facilitating the addition of the documents to the database. Notably, she concluded by asking for volunteers to help in the posting of “thousands more pharma documents to DIDA to increase the amount of data about practices that degrade the way drugs are prescribed publically available” (see Snapshot February 22, 2010). [see Background section for additional information]

Recommendations:
No recommended action at this time.

Recommendation Tactic:

Excerpt:

Background:

Notes:

Website User Info:

Language:

English Spanish none

OEO:

Infominder:

PDF:

Relevant Blog / DG:

Other Topics:

None

Last Updated:

04/19/2010

Web Site Name:

Domain Registrant:

No Stakeholder specified

Analysis:

_Earlier this week, a Pharmagossip entry suggested
a “connection” between SEROQUEL
and Wayne L Pines, a consultant who “helps companies…in crisis.”
To support that assertion, Pharmagossip linked to DIDA material that
appeared to show that AstraZeneca considered hiring Pines
to provide services to the SEROQUEL team
(see Snapshot April 13, 2010).

Previously, v-Fluence reported a Pharmagossip blog post
which amplifed an emailed announcement by Kim Klausner,
Industry Documents Digital Libraries Manager,
University of California, San Francisco (UCSF), that 241 SEROQUEL marketing
documents had been added to UCSF Drug Industry Document Archive (DIDA).
Klausner credited a Florida newspaper (the St. Petersburg Times) and
a law firm involved in the litigation (Blizzard, McCarthy and Nabers)
for facilitating the addition of the documents to the database.
Notably, she concluded by asking for volunteers to help in the posting of
“thousands more pharma documents to DIDA to increase the amount of data
about practices that degrade the way drugs are prescribed publically available”

(see Snapshot February 22, 2010).

[see Background section for additional information]

Summary:

emphasis added]

In a blog entry, Pharmagossip is once again inferring a connection between
AstraZeneca SEROQUEL and crisis communications consultant Wayne L. Pines.
Specifically, Pharmagossip has posted a link to Pines’ e-book
“Communicating in a Healthcare Crisis” under the headline “AstraZeneca –
Seroquel: Wayne’s World!”
The post is labeled with key words that include “atypical antipsychotics,”
”seroquel,” and “quetiapine.”
___________________________________________________________________________________



        

Related Topic Link -@pharmagossip

Introducing v-fluence blog

Jay Byrne - V-Fluence and the AstraZeneca Seroquel connection

@soulful sepulcher

Jay Byrne: President of v-Fluence : track me, one more time


Obviously some people are being greatly V-Influenced (not to be confused with those pesky "V" aliens) regarding this post, and are reading this little blog with great interest.

So here are just a few of my new and not so new friends.

Host Name	*removed*
IP Address	*removed*
ISP	ASTRAZENECA PHARMACEUTICALS LP
Domain	-
City	WILMINGTON
Region	DELAWARE
Country	UNITED STATES

Host Name	*removed*
IP Address	*removed*
ISP	PIPEX
Domain	ASTRAZENECA.COM
City	-
Region	-
Country	UNITED KINGDOM

Host Name	*removed*
IP Address	*removed*
ISP	ABBOTT LABORATORIES
Domain	ABBOTT.COM
City	NORTH CHICAGO
Region	ILLINOIS
Country	UNITED STATES

Host Name	*removed*pfizer.com
IP Address	*removed*
ISP	PFIZER INC
Domain	PFIZER.COM
City	NEW LONDON
Region	CONNECTICUT
Country	UNITED STATES

Host Name	mail.v-fluence.com
IP Address	*removed*
ISP	ENDECA
Domain	ENDECA.COM
City	CAMBRIDGE
Region	MASSACHUSETTS
Country	UNITED STATES

Host Name	*removed*
IP Address	*removed*
ISP	U.S. SENATE SERGEANT AT ARMS
Domain	SENATE.GOV
City	WASHINGTON
Region	DISTRICT OF COLUMBIA
Country	UNITED STATES

Host Name	*removed*
IP Address	*removed*
ISP	WORLD HEALTH ORGANIZATION
Domain	WHO.INT
City	GENEVA
Region	GENEVA
Country	SWITZERLAND